Gilead Sciences said on Monday its experimental HIV treatment was found to be statistically non-inferior to its top-selling ...

Gilead Sciences said on Monday its experimental HIV treatment met the main goal and was found to be statistically ...

Advancements in HIV/AIDS research, drug development and clinical practice since the 1980s have made it possible for people ...

Paper in @jclinicalinvest (bit.ly/497z6jo) by @HopkinsMedicine @JHUMed_ID finds patient living w/ #HIV has dramatic drop in ...

HIV and tuberculosis (TB) treatment programs have always relied on clinical trials to understand whether treatment ...

A natural vitamin A transporter, RBP4, can awaken latent HIV through NF-κB signalling, offering a new angle for cure strategies. Human immunodeficiency virus (HIV) is a virus that attacks key immune ...

Medical experts urged early testing, prevention, and treatment of human immunodeficiency virus (HIV), tuberculosis (TB), and ...

An Open and Aids Awareness Day focused on staying on medication and using health services after gender-based violence.

The Trump administration's funding cuts to PEPFAR and USAID disrupted global HIV treatment and prevention, threatening progress made over decades. Lenacapavir's FDA approval as a long-acting ...

The U.S. commitment to ending HIV is shaken. For the first time, we didn't formally mark World AIDS Day. And Trump has cut ...

SYNLAB Nigeria positions Peachy not just as a test, but as a safe entry point into a broader conversation about sexual ...